Fundraising Fox
Axial VC
Venture capitalSan Francisco · Pre-Seed–Series A · 2 people tracked
Find your way into Axial VC
11,685 people in our graph share verified history with the Axial VC team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Axial focuses on backing early-stage life sciences companies, frequently getting involved when a venture is still just an idea. The firm emphasizes partnering with founders and inventors who are driven to build enduring, independent businesses, positioning itself as an ally to the rare inventor-entrepreneur. Axial actively invites founders with life sciences ideas or companies to reach out, signaling a hands-on, relationship-driven approach to seeding and supporting new ventures in the sector.
Source: firm website, verified Sep 20, 2026.
Team · 2 people
from public directories
What they invest in
from 51 of 59 portfolio companiesBiotech ×39AI & Machine Learning ×25Healthtech ×25Deep Tech ×19Medical Devices ×12Digital Health ×9Wellness & Fitness ×7Consumer ×5
HQs:United States×31United Kingdom×2Australia×1Canada×1Switzerland×1Ecuador×1
Investments · 59 tracked
founders shown can be your intro pathBy year:2025 · 22024 · 32022 · 12020 · 22019 · 19 dated
Adaptyv Bio develops technologies for protein engineering that enable the design and testing of new proteins for applications in medicine, industrial enzymes, and functional materials.
AI & Machine LearningBiotechDeep TechHealthtechLausanne, CH
Julian Englert(CEO)inDaniel Nakhaee-Zadeh Gutierrez(Founder)inRobert KapturinGerard AntouninSam BurnsinDaniel Nakhaee-Zadeh(CTO)in
Co-investorsFoundersHAWKTAILNeer Venture PartnersRheingau FoundersUnruly CapitalY Combinator+9 more
AlgoViral helps high-growth startups scale their social media presence using AI and data-driven automation.
AI & Machine LearningEnterprise SoftwareMarketing TechSaaSLondon, GB
Jonathan Baker(Founder)inPhilip Howson(Founder)in
Co-investorsInterwoven VenturesY CombinatorAgrolimen VenturesGaingelsGlobal Founders CapitalNKM Capital+3 more
__Twitter.png)
Aperiam Bio uses computer-vision algorithms to identify "hyperfolding" protein variants with improved expression, solubility, and stability, aiming for order-of-magnitude gains in protein performance.
AI & Machine LearningBiotechDeep TechAustin, US
Austin Cole(CEO & Founder)Guillaume Cottarel(Head of Program)inRussell Durrett(Chief Business Officer)
Co-investorsCivilization Ventures Management, LlcOMX VenturesKdT Ventures
Arda develops therapeutics using single-cell computational biology to target and eliminate pathogenic cells in chronic diseases.
AI & Machine LearningBiotechDigital HealthLongevityMedical DevicesAustin, US
Adam Freund(Founder & Chief Executive Officer)inRemi-Martin Laberge(Founder and Chief Technology Officer)in
BoardVineeta Agarwala(Director)in
Co-investorsage1Andreessen HorowitzGV (Google Ventures)Olima VenturesStrawberry Creek VenturesAlumni Ventures+5 more
Attivare develops AI-powered personalized immunotherapy treatments using a proprietary biomaterial scaffold (ATTImmune) that delivers immune agonists directly to tumor microenvironments, aiming to reduce systemic toxicity in cancer and infectious disease treatment.
AI & Machine LearningBiotechMedical DevicesNatick, US
Edward Doherty(Executive Officer)Jessica McDonough(Director)Joaquim Trias(Executive Officer, Director)
BoardZeshan Muhammedi(Director)in
Co-investorsEmbark VenturesMBX CapitalUlu Ventures
Big Hat Bio develops therapeutics under development across multiple programs.
AI & Machine LearningBiotechDeep TechSan Francisco, US
Peyton Greenside(Executive Officer, Director)inMark DePristo(Executive Officer, Director)in
BoardFrancisco Gimenez(Director)inSteve Kafka(Director)Vineeta Agarwala(Director)inRobert Chess(Director)
Co-investors8VCAndreessen HorowitzBOLD LongevityFlucas VenturesGRIDS CapitalOlima Ventures+7 more
BluumBio identifies and deploys naturally occurring enzymes from fungi, trees, and bacteria to remove industrial pollutants from soil, air, and water.
BiotechCleantechHealthtechImpact & Social GoodSan Francisco, US
Katherine French(Founder)in
Co-investorsHAWKTAILOlive Tree CapitalOxonian VenturesY CombinatorAgrolimen VenturesAsymmetry Ventures+7 more
Bristle provides digital tools and insights to help people assess and improve their oral health, positioning dental care as a preventive step toward overall wellness.
Digital HealthHealthtechWellness & FitnessSan Francisco, US
David Lin(Founder)inBrian Maurer(Founder)inShivam Patel(Founder)in
Co-investorsR/GA VenturesY Combinator645 VenturesBR CapitalInitialized CapitalNorth South Ventures
CatenaBio develops precision conjugation technology using native amino acids to enable biotherapeutic fusions of small molecules, nucleic acids, enzymes, and cells.
BiotechDeep TechHealthtechMedical DevicesBerkeley, US
Marco Lobba(Founder)inMatthew Francis(Founder)inMarco Lobba, Ph.D.(Founder)in
Co-investorsCALIFORNIA INNOVATIONCivilization Ventures Management, LlcCreative Destruction Lab (CDL)FREEFLOWIaso VenturesJude Gomila+13 more
Cella Farms develops food products focused on complete protein, reduced sugar, and balanced nutrition.
ConsumerFoodTechWellness & Fitness
CHARM is a biotech company developing a next-generation menin inhibitor for acute myeloid leukemia (AML), designed to address resistance seen with first-generation approaches.
AI & Machine LearningBiotechHealthtechLondon
Lakshyaditya Singh Aithani(Executive Officer, Director)
BoardRishi Gupta(Director)inNihal Sinha(Director)inMuzammil Mansuri(Director)inGary Glick(Director)in
Co-investorsF-Prime CapitalNew Enterprise Associates (NEA)OrbiMedSR One Capital ManagementKhosla VenturesNVentures
ZymeCO creates enzyme-based bio-solutions that accelerate decomposition of organic matter in soil and turf, serving agriculture and golf course management.
AgTechBiotechImpact & Social GoodColorado Springs, US
Thaddaus Huber(Executive Officer, Director)Mark Slavens(CEO)
BoardRik Wehbring(Director)Michael Cantrell(Director)
Concerto Bio generates large-scale ecological datasets on microbial communities and uses them to develop microbe-based consumer health products for applications such as skincare, chronic disease, and nutrition.
AI & Machine LearningBiotechDeep TechCambridge, US
Jared Kehe(Executive Officer, Director)inCheri Ackerman(Executive Officer, Director)inBernardo Cervantes(Executive Officer, Director)inVera Schroeder(Director)in
BoardSarah Luppino(Director)in
Co-investorsExcelestar VenturesGolden SeedsHorizons VenturesISVM VenturesMassVentures
Deciduous Therapeutics develops small molecule and immunomodulatory therapies targeting senescent cells to treat age-related diseases including Type 1 diabetes, autoimmunity, and metabolic disorders.
BiotechDigital HealthLongevitySan Francisco, US
Robin Mansukhani(CEO and Co-Founder)inAnil Bhushan(Scientific Founder)in
BoardDylan Morris(Director)in
Co-investorsage1Bold Capital PartnersCornucopian Capital ManagementCRV (Charles River Ventures)Owl CapitalquadraScope Venture Fund+1 more
Delix Therapeutics develops third-generation, non-hallucinogenic neuroplastogens for people with neurological conditions, using a discovery platform to identify novel compounds.
BiotechDigital HealthMedical Devices
Co-investorsArtis VenturesCasa Verde CapitalDolby Family VenturesNoeticOMX VenturesPalo Santo VC+6 more
Enable Medicine builds an integrated biological data platform that organizes and links clinical, spatial, cellular, and molecular data from patients and studies into a unified index to accelerate therapeutic discovery and diagnostics for researchers.
AI & Machine LearningBiotechData & InfrastructureMenlo Park, US
Sunil Bodapati(Executive Officer, Director)inAaron Mayer(Director)in
Co-investorsBreyer CapitalInertia Ventures
FastFarma operates an online pharmacy platform serving Latin American customers, offering price-competitive medications with rapid delivery.
E-commerceHealthtechWellness & FitnessQuito, EC
Santiago Ribadeneira(Founder)inMarcelo Albuja(Founder)in
Co-investorsY Combinator0BSAsymmetry VenturesBankia Fintech VentureBuenTrip VenturesGoodwater Capital+9 more
The site presents Thai-language promotional content for online slot ("สล็อตเว็บตรง") gambling, listing direct-web slot sites with automatic wallet deposits/withdrawals and hundreds of games.
Co-investorsBantam GroupHyphen Capital
Glyphic Biotechnologies develops ProSE™, a high-throughput de novo protein sequencing technology for analyzing proteomes with single-molecule sensitivity.
BiotechDeep TechBerkeley, US
Daniel Estandian(Founder)inEd Boyden(Founder)Josh Yang(Founder)in
BoardCraig Asher(Director)inJimmy Yun(Director)in
Co-investorsArtis VenturesBlack FlagCivilization Ventures Management, LlcFoundersX VenturesHarpoon VenturesLongeVC+6 more
Gradia provides a virtual care platform for patients with chronic conditions, offering integrated communication and specialized care coordination between clinic appointments to supplement traditional in-person care.
Digital HealthHealthtechSaaSSan Francisco, US
Rithvik Seela(Founder)inAndrew Zelaya(Founder)in
Co-investorsAtlanta Tech VillageJude GomilaMaC Venture CapitalY CombinatorHarvard Management CompanyLimited Ventures+5 more
Vancouver-based computational drug discovery company using physics-based molecular simulation to target hard-to-drug proteins.
Co-investorsAngel ForumCognition FundSwan Venture FundWUTIF CapitalYork Angel Investors Inc.
Inductive Bio builds AI and machine learning software to accelerate drug discovery for pharmaceutical and biotech researchers, combining computational chemistry with expertise in translating complex drug programs from preclinical to clinical stages.
AI & Machine LearningBiotechDeep TechBrooklyn, US
Josh Haimson(Executive Officer, Director)inBen Birnbaum(Ph.D.)inAlexander Taylor(Ph.D.)in
BoardRohan Ganesh(Director)in
Co-investorsAlleyCorpAndreessen HorowitzCoalition OperatorsLux CapitalObvious VenturesAlley Robotics Ventures+4 more
Infinimmune discovers and develops antibody therapeutics using proprietary sequencing technology and AI-powered optimization.
AI & Machine LearningBiotechMedical Devices
Lance Hepler(Founder)inKatie Pfeiffer(Founder)inMichael Gibbons(Founder)inWyatt McDonnell(Founder)indavid jaffe(Founder)in
Co-investorsCivilization Ventures Management, LlcPlayground GlobalPaladin Capital GroupTrammell Venture Partners (TVP)
Insamo develops an automated platform for drug discovery that designs, synthesizes, and tests cyclic peptides at scale using machine learning and proprietary experimental data.
AI & Machine LearningBiotechDeep TechChippendale, AU
Tim Craven(CEO)inToby Passioura(CSO)inGlen McIntyre(COO)
BoardCOREY GOODMAN(Director)inMATT HERSHENSON(Director)in
Co-investorsBEVCCivilization Ventures Management, LlcMRL Ventures FundPlayground GlobalvenBio PartnersvenBio Global Strategic
FODZYME develops an enzyme powder supplement that breaks down FODMAPs in food, particularly fructans found in garlic, onions, and wheat, for people with digestive sensitivities.
BiotechConsumerFoodTechHealthtechWellness & FitnessBoston, US
Anjie Liu(Founder)inDavid Hachuel Gurska(Founder)in
Co-investorsY CombinatorAcacia Venture Capital PartnersFAST — by GETTYLABHarvard Management CompanyHENRY Collective VenturesJames Beshara Fund+1 more
Latch builds data infrastructure and software tools for biological computing, enabling researchers to program and automate biological discovery through high-throughput laboratory automation and machine learning.
AI & Machine LearningBiotechData & InfrastructureDeep Tech
Alfredo Andere(Cofounder)inKyle Giffin(Cofounder)inKenny Workman(Cofounder)in
Co-investorsCoatue ManagementFifty YearsHummingbird VenturesMantis CapitalSwift VenturesCaffeinated Capital+2 more
Lyell develops CAR T-cell therapies for cancer patients by leveraging deep expertise in T-cell biology and oncology.
BiotechDeep TechHealthtechMedical DevicesBothell, US
Stan Riddell(Executive Officer)Richard Klausner(Executive Officer, Director, Promoter)Stephen Hill(Executive Officer)inHeather Turner(Executive Officer)inRichard Goold(Executive Officer)inMargo Roberts(Executive Officer)
Co-investorsARCH Venture PartnersForesite CapitalvenBio Partners8VC
Machine learning and data platform for understanding how diseases fight back and resist therapies
David Li(Founder)in
Co-investorsHAWKTAILJude GomilaValkyrieBrightEdgeHOF CapitalObvious Ventures+3 more
Nuanced Health develops healthcare solutions, though the specific product focus is not detailed on this team page.
AI & Machine LearningBiotechDeep TechHealthtechLos Angeles, US
Sarkis Mazmanian(Co-Founder)inYan Yang(Chief Scientific Officer)in
Co-investorsFREEFLOWOpen Field Capital
Wellness & FitnessLos Angeles, US
Kyle Pierce(Executive Officer, Director)inMorgan Hewett(Executive Officer, Director)in
Co-investorsBread And Butter Ventures, LlcMedMountain VenturesTechstarsBread Butter VenturesBright VenturesCollab Capital+1 more
Papa is a platform that connects older adults and families with trained companion caregivers for in-home companionship and support services.
ConsumerDigital HealthHealthtechSocialWellness & FitnessMiami, US
Andrew Parker(Founder/CEO)inAlfredo Vaamonde(Co-Founder)inAndrew(CEO)inCharles Hector(Executive Officer)
BoardByron Ling(Director)inFatima Husain(Director)in
Co-investorsComcast VenturesIntegra GroupeMagnify VenturesSoftBank Vision FundThe Chernin Group (TCG Crypto)Y Combinator+12 more
Parallel Bio develops human immune organoids and computational tools to predict drug efficacy across diverse patient populations, replacing animal testing in drug discovery.
AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US
Robert DiFazio(Founder)inJuliana Hilliard(Founder)in
Co-investorsAIX VenturesBreakout VenturesHumba VenturesImmeasurableJulian CapitalMetaplanet+18 more
.jpeg){kind=logo}
Parallel Health offers a skincare product line addressing aging through microbiome science, including peptide creams and cleansers designed to target the hallmarks of skin aging.
BiotechConsumerDigital HealthDirect to ConsumerHealthtechWellness & Fitness
Nathan Brown(Founder)in
Co-investorsFirst In VenturesHyphen Capital
Potion creates automation and workflow solutions for beauty and personal care companies to reduce time spent on repetitive tasks.
AI & Machine LearningConsumerEnterprise SoftwareMarketing TechSaaSSan Francisco, US
Yahya Syed(Founder)inHejab Malik(Founder)inAlex Stec(Founder)in
Co-investorsHAWKTAILY CombinatorBeagle VenturesHarvard Management CompanyOffline VenturesSeven Seven Six+1 more
Reference Medicine supplies biological specimens to researchers and diagnostics developers working on cancer diagnostic tools.
AI & Machine LearningB2B MarketplacesBiotechDigital HealthHealthtechMedical Devices
Co-investorsMetaplanet
Replay develops gene therapies for patients with rare genetic diseases.
BiotechHealthtechLongevity
Lachlan MacKinnon(CEO and Founder)Adrian Woolfson(Founder)Robert Coffin(Executive Chairman)Maria Castner-Miller(General Counsel)inRenata Martin(VP & Head of Gene Therapy)inSaurabh Sharma(VP & Head of CMC)
Co-investorsArtis VenturesOMX VenturesSolari Capital
Rubi develops biotechnology solutions for sustainable manufacturing in the fashion and textiles industry.
Advanced ManufacturingBiotechCleantechClimate TechNew MaterialsSan Francisco, US
Neeka Mashouf(Co-founder)inLeila Mashouf(Co-founder)in
BoardDaria Hosseinyoun(Director)inRohini Finch(Director)in
Co-investorsAP VenturesClimacticCollaborative FundDarco CapitalJuniperNecessary Ventures+5 more
.jpeg){kind=logo}
Scispot provides automated sample tracking and traceability software for laboratory environments, replacing manual processes and spreadsheets with end-to-end logging and monitoring capabilities.
AI & Machine LearningData & InfrastructureEnterprise SoftwareSaaSKitchener, CA
Guru Singh(Founder)inSatya Singh(Founder)in
Co-investorsY CombinatorAvenue Growth PartnersBreakwater VenturesHarvard Management CompanyIncisive VenturesPack Ventures
Seranova is a biotech company that combines REAP autoantibody profiling with clinically linked patient cohorts to identify naturally occurring protective autoantibodies against specific extracellular targets and translate those protective associations into therapeutic hypotheses.
AI & Machine LearningBiotechDeep TechNew Haven, US
Aaron Ring(Manager)inBeatrice McQueen(Executive Officer)
BoardJim Tananbaum(Manager)
Co-investorsARCH Venture PartnersForesite Capital
Serna builds a platform to unlock the transcriptome as a drug target for drug discovery.
AI & Machine LearningBiotechDeep TechHealthtechOntario, US
Rabia Khan(Founder)in
Co-investorsBackedHummingbird VenturesLifeforce CapitalY CombinatorAME Cloud VenturesAmino Collective+3 more
Simcha is a biotechnology company developing new cancer medicines based on immune biology research.
BiotechHealthtechNew Haven, US
Aaron Ring(Executive Officer, Director)inBeatrice McQueen(Chief Operating Officer)inSanuj Ravindran(Chief Executive Officer)Jeremy Barton(Chief Medical Director)Hirdesh Uppal(Senior Vice President Translational Research and Development Sciences)Joseph Catino(Executive Officer)
Co-investorsConnecticut InnovationsPfizer Venture InvestmentsSR One Capital ManagementBiotechnology Value FundRock Springs CapitalSamsara BioCapital
Stately Bio develops stem cell-derived regenerative and cell therapies using a machine learning platform that measures cell identity, behavior, and maturation directly from live-cell, label-free imaging.
AI & Machine LearningBiotechMedical Devices
Frank Li(Founder & CEO)Christian Elabd, PhD(Head of Biology)
Co-investorsAIX VenturesFoothill VenturesMitsui Global InvestmentBoxOne VenturesCaffeinated CapitalDimension Capital+1 more
Stipple Bio develops targeted oncology therapies that act on tumor-specific cell surface epitopes to expand druggable targets and improve therapeutic index for cancer patients.
BiotechHealthtechCambridge, US
Aaron Ring(Co-founder)inAashish Manglik(Co-founder)inJeff Landau(Chief Executive Officer)inRoland Gendron(Chief Business Officer)inMichelle Zhang(Chief Scientific Officer)in
BoardVineeta Agarwala(Director)in
Co-investorsRA CapitalAndreessen HorowitzGV (Google Ventures)Magnetic VenturesOMX VenturesLoLa Capital Partners+1 more
SynsoryBio develops protein-based drugs that detect their location in the body and activate only at diseased tissue, with applications across cancer and autoimmune conditions.
BiotechHealthtechBoston, US
Elliot Tague(Founder)inNathan Tague(Founder)in
Co-investorsGurtin VenturesY CombinatorAgrolimen VenturesFriends Family CapitalUnpopular Ventures
Talus develops a proprietary platform that measures and modulates the regulome—the body's gene expression control system—in native cellular contexts.
AI & Machine LearningBiotechDeep TechHealthtechSeattle, US
Alex Federation(Founder)inLindsay Pino(Founder)inAlex Federation, Ph.D.(Chief Executive Officer & Co-Founder)Lindsay Pino, Ph.D.(Chief Technology Officer & Co-Founder)
BoardOmri Amirav-Drory(Director)inJ. Seth Strattan(Director)in
Co-investorsFarvatn VentureFifty YearsFundersClubJude GomilaNFXTwo Bear Capital+9 more
Talus is a drug discovery company with a proprietary platform that measures and modulates the regulome — the transcription factors, cofactors, and splicing regulators controlling gene expression — in live cells using functional proteomics and AI models.
AI & Machine LearningBiotechDeep Tech
Alex Federation(Ph.D.)Christopher Joyce(MBA)Lindsay Pino(Ph.D.)Michelle BriscoeWill Fondrie(Ph.D.)
Thatch provides APIs and embeddable components that enable platforms and software providers to offer ICHRA (Individual Coverage Health Reimbursement Arrangement) benefits to their customers.
Enterprise SoftwareFintechHealthtechHR TechInsurTechSaaS
Adam Stevenson(Founder)in
Co-investorsAndreessen HorowitzAvid VenturesGeneral PartnershipIndex VenturesLux CapitalSemperVirens Venture Capital+3 more
Think Bioscience develops new medicines for diseases with limited treatment options through synthetic biology and computational chemistry.
BiotechDeep Tech
Co-investorsAV8 VenturesBuff Gold VenturesColorado BioScience AssociationCU Healthcare Innovation FundWireframe VenturesInnovation Endeavors
Tilda Research provides AI-powered teammates designed to streamline clinical trial operations for sponsors, contract research organizations, and research sites by automating data management and workflow processes.
AI & Machine LearningHealthtechMedical Devices
Ram Yalamanchili(Founder/CEO)in
Co-investors8VCOptum VenturesStorm Ventures
Trestle Biotherapeutics develops bioengineered implantable tissues designed to treat end-stage renal disease, aiming to get patients off dialysis and eventually provide replacement organs.
BiotechDeep TechHealthtechMedical DevicesSan Diego, US
Ben Shepherd(Founder)inAlice Chen(Founder)inAlice Chen, PhD(Co-founder and Chief Scientific Officer)inBen Shepherd, PhD(Co-Founder and Chief Executive Officer)
Co-investorsY CombinatorC3 VenturesDraper AssociatesAcequia Capital (AceCap)Agrolimen VenturesAsymmetry Ventures+4 more
Zeit Medical develops a wearable headband with AI-powered sensors that detects strokes in real time and automatically alerts emergency services, targeting patients at high risk for stroke who may be asleep or unable to call for help themselves.
HealthtechMedical DevicesSan Francisco, US
Orestis Vardoulis(Founder)inUrs Naber(Founder)in
Co-investorsCitta CapitalFoundersY CombinatorGaingelsHike VenturesOriginal Capital+3 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Appia BioImmulusLaddertxOmicaTryminded
Portfolio news
latest coverage across their companies
Adaptyv · thesaasnews.com · Aug 28, 2026
Scispot · ycombinator.com · May 26, 2026
Parallel Bio · finsmes.com · Jun 12, 2025
Inductive Bio · prnewswire.com · May 7, 2025
Stately Bio · finsmes.com · May 1, 2025
Frequently asked questions
- How many investments has Axial VC made?
- Axial VC has 59 tracked investments, 1 of which have exited, including 3 dated in the last 24 months.
- What stage does Axial VC invest at?
- Axial VC invests at the Pre-Seed, Seed, Series A stages.
- What is Axial VC's typical check size?
- Axial VC typically writes checks of $100K – $5M.
- What sectors does Axial VC focus on?
- Axial VC focuses on AgTech, AI & Machine Learning, Biotech, Deep Tech, FoodTech, Healthtech, Medical Devices.
- Where is Axial VC located?
- Axial VC is headquartered in San Francisco, US.
- Does Axial VC lead rounds?
- Axial VC typically participates in rounds rather than leading them.
Co-investors · 4
Fifty Years (50Y) is a pre-seed and seed-focused venture capital firm that backs founders using technology to solve major global problems, and also helps start companies.
Pioneer Fund is a venture capital firm investing in the top Y Combinator startups.
Susa Ventures operates two early-stage technology funds that invest in companies leveraging data, network effects, and economies of scale.
UpHonest Capital is a Silicon Valley-based investment firm founded in 2017 that supports cross-border entrepreneurship and investment between China and the United States, and runs media, scout, and incubation programs.
Firms observed investing alongside Axial VC, from public investor directories. Shared companies are the overlap with Axial VC's recorded portfolio.
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Snatched Ventures is a San Francisco-based early-stage venture capital firm backing DeepTech startups focused on sustainable innovation and operational transformation. It is led by a two-GP team combining corporate development and institutional investment management experience.
Overwater Ventures is an early-stage venture firm that partners with pre-seed and seed stage founders working on large-scale problems, offering hands-on support across launch strategy, go-to-market, fundraising, and marketing.
Voima Ventures is a deep tech venture capital firm that backs founders building global solutions across people, planet, and industry, from technology spin-offs to scaling companies.
Artesian is a deep tech and hardware venture capital investor that builds funds around specific institutional backers — governments, corporations, universities, industry bodies and super funds — to pursue both financial returns and strategic outcomes in critical industries.